Ligand profile
2LF
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_32224 — DNA polymerase IV
Identifiers
Database identifiers and provenance.
- Ligand ID
2LF- PDB
4tqs- UniProt (similar protein)
Q97W02- Target protein
- KP13_32224
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 185.8
- −1 ≤ LogP ≤ 5 -1.49
- MW ≤ 500 Da 345.2
- LogP ≤ 5 -1.49
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 9
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 185.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C1[C@@H]([C@H]2[C@H](c3nc4c(n3[C@@H]1O2)N=C(NC4=O)N)OP(=O)(O)O)OC1[C@@H]([C@H]2[C@H](c3nc4c(n3[C@@H]1O2)N=C(NC4=O)N)OP(=O)(O)O)O
InChI=1S/C10H12N5O7P/c11-10-13-7-4(9(17)14-10)12-8-6(22-23(18,19)20)5-2(16)1-3(21-5)15(7)8/h2-3,5-6,16H,1H2,(H2,18,19,20)(H3,11,13,14,17)/t2-,3+,5-,6+/m0/s1InChI=1S/C10H12N5O7P/c11-10-13-7-4(9(17)14-10)12-8-6(22-23(18,19)20)5-2(16)1-3(21-5)15(7)8/h2-3,5-6,16H,1H2,(H2,18,19,20)(H3,11,13,14,17)/t2-,3+,5-,6+/m0/s1
WUVBJPHCDIFJHL-YELPUOMLSA-NWUVBJPHCDIFJHL-YELPUOMLSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00817
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 2LF →
- PDB RCSB structure 4tqs →
- UniProt UniProt Q97W02 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “2LF”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_32224.
PDB 31
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 3
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).